The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Preconditioning of the Tumor Vasculature and Tumor Cells by Intermittent Hypoxia: Implications for Anticancer Therapies
Open accessAbstract
Hypoxia is a common feature in tumors associated with an increased resistance of tumor cells to therapies. In addition to O2 diffusion–limited hypoxia, another form of tumor hypoxia characterized by fluctuating changes in pO2 within the disorganized tumor vascular network is described. Here, we postulated that this form of intermittent hypoxia promotes endothelial cell survival, thereby extending the concept of hypoxia-driven resistance to the tumor vasculature. We found that endothelial cell exposure to cycles of hypoxia reoxygenation not only rendered them resistant to proapoptotic stresses, including serum deprivation and radiotherapy, but also increased their capacity to migrate and organize in tubes. By contrast, prolonged hypoxia failed to exert protective effects and even seemed deleterious when combined with radiotherapy. The use of hypoxia-inducible factor-1α (HIF-1α)–targeting small interfering RNA led us to document that the accumulation of HIF-1α during intermittent hypoxia accounted for the higher resistance of endothelial cells. We also used an in vivo approach to enforce intermittent hypoxia in tumor-bearing mice and found that it was associated with less radiation-induced apoptosis within both the vascular and the tumor cell compartments (versus normoxia or prolonged hypoxia). Radioresistance was further ascertained by an increased rate of tumor regrowth in irradiated mice preexposed to intermittent hypoxia and confirmed in vitro using distinctly radiosensitive tumor cell lines. In conclusion, we have documented that intermittent hypoxia may condition endothelial cells and tumor cells in such a way that they are more resistant to apoptosis and more prone to participate in tumor progression. Our observations also underscore the potential of drugs targeting HIF-1α to resensitize the tumor vasculature to anticancer treatments. (Cancer Res 2006; 66(24): 11736-44)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“These mechanisms include a decrease in topo alpha mRNA and protein,878 changes in proteasome function,879 and small interfering RNA.880”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [880]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“(2) CIH results in molecular changes that promote cancer progression or metastases.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [880]
The cited source says what the claim attributes to it.
In the citing paper
“In vitro models have provided two main findings: (1) CIH results in changes that are distinct from sustained hypoxia;”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [880]
The cited source says what the claim attributes to it.
In the citing paper
“Other studies focused on why cancer cells exposed to CIH may be more resistant to therapy.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [880]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Intermittent blood flow in a murine tumor: radiobiological effects.
Chaplin, D. J., Olive, P. L., & Durand, R. E. (1987) · PubMed · Cited by 435
Kimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papahadjopoulos, D., Hong, K., & Dewhirst, M. W. (1996) · PubMed · Cited by 358
Microenvironment-induced cancer metastasis
Rofstad, E. K. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138259 · Cited by 335
The hypoxic tumour microenvironment and metastatic progression
Subarsky, P., & Hill, R. P. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022939318102 · Cited by 327
Cited by
Sorted by citations
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Self-citationEmami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Rockwell, S., Dobrucki, I. T., Kim, E. Y., Marrison, S. T., & Vu, V. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167087 · Cited by 528
Balligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
Self-citationBroad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El‐Rayes, B. F., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 479
Garvey, J., Taylor, C. T., & McNicholas, W. T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00111208 · Cited by 367
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Cycling hypoxia: A key feature of the tumor microenvironment
Michiels, C., Tellier, C., & Féron, O. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.004 · Cited by 244
Self-citationPolet, F., & Féron, O. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12016 · Cited by 232
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Dewhirst, M. W. (2009) · Radiation Research · doi:10.1667/rr1926.1 · Cited by 228
Lu, L., Payvandi, F., Wu, L., Zhang, L., HARIRI, R. J., Man, H., Chen, R. S., Muller, G. W., Hughes, C. C. W., Stirling, D., et al. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.08.003 · Cited by 228
Boidot, R., Végran, F., Meulle, A., Breton, A. L., Dessy, C., Sonveaux, P., Lizard‐Nacol, S., & Féron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2474 · Cited by 238
Self-citationSaxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 223
Hypoxia and adaptive landscapes in the evolution of carcinogenesis
Gillies, R. J., & Gatenby, R. A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9065-z · Cited by 217
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Saxena, K., Jolly, M. K., & Balamurugan, K. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100845 · Cited by 205
CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
de Jong, M. C., Pramana, J., van der Wal, J. E., Lacko, M., Peutz‐Kootstra, C. J., de Jong, J. M., Takes, R. P., Kaanders, J. H. A. M., van der Laan, B. F. A. M., Wachters, J. E., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0799 · Cited by 187
Harada, H., Inoue, M., Itasaka, S., Hirota, K., Morinibu, A., Shinomiya, K., Zeng, L., Ou, G., Zhu, Y., Yoshimura, M., et al. (2012) · Nature Communications · doi:10.1038/ncomms1786 · Cited by 183
The Pervasive Presence of Fluctuating Oxygenation in Tumors
Cárdenas-Navia, L. I., Mace, D., Richardson, R. A., Wilson, D. F., Shan, S., & Dewhirst, M. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6387 · Cited by 179
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Jubb, A. M., Buffa, F. M., & Harris, A. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00944.x · Cited by 175
The polymorphic and contradictory aspects of intermittent hypoxia
Almendros, I., Wang, Y., & Gozal, D. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00089.2014 · Cited by 174
Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours
Toffoli, S., & Michiels, C. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06454.x · Cited by 168
Self-citationWang, P., Li, X., Yao, C., Wang, W., Zhao, M., El‐Toni, A. M., & Zhang, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.017 · Cited by 161
Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia
Bartoszewska, S., & Collawn, J. F. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00212-1 · Cited by 155
Malec, V., Gottschald, O. R., Li, S., Rose, F., Seeger, W., & Hänze, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.008 · Cited by 149
Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells
Wang, J., Chen, T., Jiang, J., Shi, H., Gui, C., Luo, R., Xie, X.-J., Xiang, M., & Zhang, X. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00716.x · Cited by 149
Matsumoto, S., Yasui, H., Mitchell, J. B., & Krishna, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2821 · Cited by 144
Tissue necrosis and its role in cancer progression
Karsch-Bluman, A., Feiglin, A., Arbib, E., Stern, T., Shoval, H., Schwob, O., Berger, M., & Benny, O. (2018) · Oncogene · doi:10.1038/s41388-018-0555-y · Cited by 145
Acute versus chronic hypoxia in tumors
Bayer, C., & Vaupel, P. W. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0085-4 · Cited by 140
Intermittent hypoxia induces a metastatic phenotype in breast cancer
Chen, A., Sceneay, J., Gödde, N., Kinwel, T., Ham, S., Thompson, E. W., Humbert, P. O., & Möller, A. (2018) · Oncogene · doi:10.1038/s41388-018-0259-3 · Cited by 133
Matsumoto, S., Batra, S., Saito, K., Yasui, H., Choudhuri, R., Gadisetti, C., Subramanian, S., Devasahayam, N., Munasinghe, J., Mitchell, J. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2025 · Cited by 129
Wu, W., Chen, F., Cui, X., Yang, L., Chen, J., Zhao, J., Huang, D., Liu, J., Yang, L., Zeng, J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31605 · Cited by 127
Hsieh, C. (2010) · Oncology Reports · doi:10.3892/or_00001027 · Cited by 129
Hypoxia in prostate cancer: A powerful shield against tumour destruction?
Marignol, L. H., Coffey, M. A., Lawler, M., & Hollywood, D. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.006 · Cited by 125
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Ito, K., Stannard, K. A., Gabutero, E., Clark, A. M., Neo, S., Onturk, S., Blanchard, H., & Ralph, S. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9388-2 · Cited by 131
Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea
Almendros, I., Montserrat, J. M., Torres, M., Bonsignore, M. R., Chimenti, L., Navajas, D., & Farré, R. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.08.012 · Cited by 123
Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors
Wan, L., Neumann, C. A., & LeDuc, P. R. (2020) · Lab on a Chip · doi:10.1039/c9lc00550a · Cited by 120
Bader, S. B., Dewhirst, M. W., & Hammond, E. M. (2020) · Cancers · doi:10.3390/cancers13010023 · Cited by 127
Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
Butturini, E., de Prati, A. C., Boriero, D., & Mariotto, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174305 · Cited by 123
Hsieh, C., Shyu, W., Chiang, C.-Y., Kuo, J.-W., Shen, W., & Liu, R.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023945 · Cited by 117
Chou, C.-W., Wang, C.-C., Wu, C., Lin, Y., Lee, Y.-C., Cheng, Y.-W., & Hsieh, C. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos195 · Cited by 111
Intermittent Hypoxia Furthers the Rationale for Hypoxia-Inducible Factor-1 Targeting
Dewhirst, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4744 · Cited by 108
Inside the hypoxic tumour: reprogramming of the DDR and radioresistance
Begg, K., & Tavassoli, M. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00311-0 · Cited by 109
Nitric oxide delivery to cancer: Why and how?
Sonveaux, P., Jordan, B. F., Gallez, B., & Féron, O. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.018 · Cited by 103
Hypoxia, notch signalling, and prostate cancer
Marignol, L. H., Rivera-Figueroa, K., Lynch, T. H., & Hollywood, D. P. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.110 · Cited by 95
Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1
Toffoli, S., Roegiers, A., Féron, O., Steenbrugge, M. V., Ninane, N., Raes, M. J., & Michiels, C. (2009) · Angiogenesis · doi:10.1007/s10456-009-9131-y · Cited by 91
Self-citationSchubert, T., Xhema, D., Vériter, S., Schubert, M., Behets, C., Delloye, C., Gianello, P., & Dufrane, D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.009 · Cited by 90
Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells
Bhaskara, V. K., Mohanam, I., Rao, J. S., & Mohanam, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030905 · Cited by 78
Optical imaging of tumor hypoxia dynamics
Palmer, G. M., Fontanella, A. N., Zhang, G., Hanna, G., Fraser, C. L., & Dewhirst, M. W. (2010) · Journal of Biomedical Optics · doi:10.1117/1.3523363 · Cited by 78
Tumor Hypoxia, Dna Repair and Prostate Cancer Progression: New Targets and New Therapies
Chan, N. H. L., Milosevic, M., & Bristow, R. G. (2007) · Future Oncology · doi:10.2217/14796694.3.3.329 · Cited by 77
Liu, Y., Song, X., Wang, X.-W., Wei, L., Liu, X., Yuan, S., & Lv, L. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22739 · Cited by 74
Sorg, B. S., Hardee, M. E., Agarwal, N., Moeller, B. J., & Dewhirst, M. W. (2008) · Journal of Biomedical Optics · doi:10.1117/1.2837439 · Cited by 75
Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors
Yeom, C. J., Gotö, Y., Zhu, Y., Hiraoka, M., & Harada, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131113949 · Cited by 70
Chen, W.-L., Wang, C.-C., Lin, Y., Wu, C., & Hsieh, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0758-8 · Cited by 72
Hsieh, C., Wu, C., Lee, H., Liang, J., Yu, C.-Y., & Lin, Y. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.009 · Cited by 66
Intermittent hypoxia and cancer: Undesirable bed partners?
Almendros, I., & Gozal, D. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.08.008 · Cited by 69
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 69
Self-citationThe Role of Hypoxia in Vascular Injury and Repair
Walshe, T. E., & D'Amore, P. A. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151501 · Cited by 70
Novel Imaging Provides New Insights into Mechanisms of Oxygen Transport in Tumors
Hardee, M. E., Dewhirst, M. W., Agarwal, N., & Sorg, B. S. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167122 · Cited by 61
Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway
Delprat, V., Tellier, C., Demazy, C., Raes, M. J., Féron, O., & Michiels, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-57677-5 · Cited by 69
Self-citationDinh (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.883 · Cited by 59
RetractedMarcus, K. J., & Haas-Kogan, D. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00008-x · Cited by 56
D’Aiuto, N., Hochmann, J., Millán, M., Paolo, A. D., Bologna‐Molina, R. E., Sotelo-Silveira, J. R., & Arocena, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-26205-y · Cited by 58
Lafosse, A., Desmet, C. M., Aouassar, N., André, W., Hanet, M.-S., Beauloye, C., Vanwijck, R., Poirel, H. A., Gallez, B., & Dufrane, D. (2015) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000001437 · Cited by 54
Valable, S., Petit, E., Roussel, S., Marteau, L., Toutain, J., Divoux, D., Sobrio, F., Delamare, J., Barré, L., & Bernaudin, M. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.01.010 · Cited by 51
Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response
Shembrey, C., Huntington, N. D., & Hollande, F. (2019) · Cancers · doi:10.3390/cancers11091217 · Cited by 54
Wirthner, R., Wrann, S., Balamurugan, K., Wenger, R. H., & Stiehl, D. P. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn231 · Cited by 51
Olbryt, M., Habryka, A., Student, S., Jarząb, M., Tyszkiewicz, T., & Lisowska, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105104 · Cited by 47
The role of HIFs in ischemia-reperfusion injury
Tennant, D. A., & Howell, N. J. (2014) · Hypoxia · doi:10.2147/hp.s49720 · Cited by 47
Palmer, G. M., Viola, R. J., Schroeder, T., Yarmolenko, P., Dewhirst, M. W., & Ramanujam, N. (2009) · Journal of Biomedical Optics · doi:10.1117/1.3103586 · Cited by 46
Noninvasive mapping of spontaneous fluctuations in tumor oxygenation using MRI
Magat, J., Jordan, B. F., Cron, G. O., & Gallez, B. (2010) · Medical Physics · doi:10.1118/1.3484056 · Cited by 46
Considering the role of pyruvate in tumor cells during hypoxia
Roudier, E. A., & Perrin, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.02.003 · Cited by 45
Bol, V., & Grégoire, V. (2014) · BioMed Research International · doi:10.1155/2014/696028 · Cited by 49
Daneau, G., Boidot, R., Martinive, P., & Féron, O. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0583 · Cited by 44
Self-citationMartinive, P., Defresne, F., Quaghebeur, E., Daneau, G., Crokart, N., Grégoire, V., Gallez, B., Dessy, C., & Féron, O. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06798.x · Cited by 44
Self-citationThe Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Lee, S. H., Lee, J. H., Han, Y., Ryu, J. M., Yoon, Y. M., & Han, H. J. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0128-8 · Cited by 46
HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia
Wrann, S., Kaufmann, M. R., Wirthner, R., Stiehl, D. P., & Wenger, R. H. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0311 · Cited by 41
Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis
Oliveira, J., Ribeiro, C., Barros, R., Gomes, C., de Matos, A., Reis, C. A., Rutteman, G. R., & Gärtner, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134458 · Cited by 41
Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment
Leroi, N., Lallemand, F., Coucke, P. A., Noël, A., & Martinive, P. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00078 · Cited by 41
Self-citationTellier, C., Desmet, D., Petit, L., Finet, L., Graux, C., Raes, M. J., Féron, O., & Michiels, C. (2015) · Neoplasia · doi:10.1016/j.neo.2014.11.003 · Cited by 39
Self-citationSantara, S. S., Roy, J., Mukherjee, S., Bose, M., Saha, R., & Adak, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304145110 · Cited by 39
Hypoxia as a Cause of Treatment Failure in Non–Small Cell Carcinoma of the Lung
Brustugun, O. T. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.11.006 · Cited by 38
Imaging the Impact of Nox4 in Cycling Hypoxia-mediated U87 Glioblastoma Invasion and Infiltration
Hsieh, C., Chang, H., Shen, W., Shyu, W., & Liu, R.-S. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0516-0 · Cited by 36
Clarke, R. H., Moosa, S., Anzivino, M. J., Wang, Y., Floyd, D. H., Purow, B. W., & Lee, K. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111199 · Cited by 37
Danhier, P., Krishnamachary, B., Bharti, S. K., Kakkad, S. M., Mironchik, Y., & Bhujwalla, Z. M. (2015) · Neoplasia · doi:10.1016/j.neo.2015.11.007 · Cited by 37
Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Marín‐Hernández, Á., Aguilar-Ponce, J. L., Mandujano-Tinoco, E. A., Meneses, A., & Moreno‐Sánchez, R. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391561 · Cited by 37
Kang, M. J., Jung, S. M., Kim, M. J., Bae, J. H., Kim, H. B., Kim, J. Y., Park, S. J., Song, H. S., Kim, D. W., Kang, C., et al. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06725.x · Cited by 36
Gao, Z., Zhao, Q., Xu, Y., & Wang, L. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02278-5 · Cited by 34
Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 39
Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution
Edgar, L. J., Vellanki, R. N., McKee, T. D., Hedley, D. W., Wouters, B. G., & Nitz, M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201607483 · Cited by 34
Potassium and Sodium Channels and the Warburg Effect: Biophysical Regulation of Cancer Metabolism
Iorio, J., Petroni, G., Duranti, C., & Lastraioli, E. (2019) · Bioelectricity · doi:10.1089/bioe.2019.0017 · Cited by 33
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity
Lai, V., Neshat, S. Y., Rakoski, A. I., Pitingolo, J., & Doloff, J. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113920 · Cited by 33
Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo
Terraneo, L., Bianciardi, P., Caretti, A., Ronchi, R., & Samaja, M. (2010) · The Prostate · doi:10.1002/pros.21160 · Cited by 29
Yu, S., Wang, C., Cheng, Q., Xu, H., Zhang, S., Lu, L., Zhang, Q., Gu, X., & Ding, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109923 · Cited by 30
Metadata
- Authors
- Martinive, P., Defresne, F., Bouzin, C., Saliez, J., Lair, F., Grégoire, V., Michiels, C., Dessy, C., & Feron, O.
- Affiliations
- UCLouvain (BE)
- 2Center for Molecular Imaging and Experimental Radiotherapy, Brussels, Belgium; and
- University of Namur (BE)
- 1Unit of Pharmacology and Therapeutics (FATH 5349), Université Catholique de Louvain (UCL);
- Venue
- Cancer Research
- Published
- 2006-12-15
- Volume
- 66
- Issue
- 24
- Pages
- 11736-11744
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2151713230
- Semantic Scholar
- 6e13dac6f9dae03ad2cb789557b6f9e7d3000bb7
- Cited by
- 190
- References
- 45
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 11 · 2022: 6 · 2021: 6 · 2020: 15 · 2019: 5 · 2018: 5 · 2017: 9 · 2016: 15 · 2015: 17 · 2014: 11 · 2013: 8 · 2012: 12
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
- orbi.uliege.be
- Licence
- other-oa
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Namur (publishedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Funders
- Fonds De La Recherche Scientifique - FNRS
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- intermittent hypoxia, tumor hypoxia, tumor vasculature, endothelial cells, hypoxia/reoxygenation, radioresistance (biology), HIF-1α, apoptosis, tumor cell migration, tumor angiogenesis, tumor regrowth, radiosensitization, siRNA
- MeSH terms
- Animals, Cell Division, Humans, Liver Neoplasms, Male, Mice, Inbred Strains, Neovascularization, Pathologic, Cell Hypoxia, Ischemic Preconditioning, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review